For the quarter ending 2025-09-30, UHS had -$24,797K decrease in cash & cash equivalents over the period. $151,786K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net income attributable to uhs | 379,105 | 362,612 | 321,628 | 337,047 |
| Depreciation & amortization | 155,060 | 152,004 | 148,345 | 146,781 |
| Loss (gain) on sales of assets and businesses | 0 | -2,833 | - | 4,796 |
| Stock-based compensation expense | 24,879 | 24,112 | 21,595 | 26,622 |
| Costs related to extinguishment of debt | - | - | - | 0 |
| Provision for asset impairment | - | - | - | 0 |
| Accounts receivable | 201,574 | -125,738 | 218,374 | -55,652 |
| Accrued interest | -11,584 | 15,618 | -11,086 | -14,576 |
| Accrued and deferred income taxes | -16,626 | 144,554 | -88,641 | -23,600 |
| Other working capital accounts | 4,909 | -68,148 | 42,824 | -60,568 |
| Deferred grant revenue | - | - | - | 0 |
| Other assets and deferred charges | 7,225 | 21,915 | 489 | 6,542 |
| Other, net | 2,971 | 12,332 | 3,811 | -3,921 |
| Accrued insurance expense, net of commercial premiums paid | 82,358 | 47,362 | 47,334 | 79,290 |
| Payments made in settlement of self-insurance claims | - | - | 20,705 | 70,440 |
| Payments made in settlement of self-insurance claims, net of commercial insurance reimbursements | 78,197 | 84,781 | - | - |
| Net cash provided by operating activities | 380,678 | 548,978 | 360,048 | 658,437 |
| Property and equipment additions | 228,892 | 266,014 | 239,026 | 245,945 |
| Proceeds received from sales of assets and businesses | 0 | 2,980 | - | 8,344 |
| Acquisition of businesses and property | 39,458 | 0 | 8,314 | 18,998 |
| Outflows from foreign exchange contracts that hedge our net u.k. investment | -17,051 | 42,707 | 23,695 | -48,527 |
| Costs incurred for purchase and development of enterprise resource planning application | 18,676 | - | - | - |
| Decrease in capital reserves of commercial insurance subsidiary | -562 | 198 | 264 | -79 |
| Net cash used in investing activities | -269,413 | -305,939 | -271,299 | -207,993 |
| Repayments of long-term debt | 9,243 | 9,435 | 9,113 | 168,486 |
| Additional borrowings | 114,385 | -57,853 | 152,454 | 0 |
| Financing costs | 382 | - | - | 2,574 |
| Repurchase of common shares | 237,399 | 155,157 | 223,385 | 250,166 |
| Dividends paid | 12,468 | 12,900 | 13,534 | 13,044 |
| Issuance of common stock | 3,982 | 4,479 | 3,658 | 4,206 |
| Profit distributions to noncontrolling interests | 788 | 3,709 | 5,912 | 717 |
| Purchase (sale) of ownership interests by (from) minority member | 7,392 | 6,924 | 4,412 | 4,021 |
| Net cash used in financing activities | -134,521 | -227,651 | -91,420 | -426,760 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -1,541 | 2,286 | 1,645 | -3,529 |
| Decrease in cash, cash equivalents and restricted cash | -24,797 | 17,674 | -1,026 | 20,155 |
| Cash and cash equivalents at beginning of period | 241,400 | 223,726 | 224,752 | 204,597 |
| Cash and cash equivalents at end of period | 216,603 | 241,400 | 223,726 | 224,752 |
UNIVERSAL HEALTH SERVICES INC (UHS)
UNIVERSAL HEALTH SERVICES INC (UHS)